Marc Machaalani, MD on MAdCAM-1

• November 5, 2025

Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications

• by Thomas McMaster, Niall McVeigh, David C. Chen, Abdullah Al-Khanaty, Kieran Sandhu, Jonathon Carll, Dixon T. Woon, Declan G. Murphy, Nathan Lawrentschuck, Lewis Au, Muhammad Ali, Shankar Siva, Marlon Perera

• July 17, 2026

Dana-Farber Research News 12.15.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from November 16 - 30.

• December 15, 2025

• 19 min

Impact of Azygos Venous Pathway Status on Surgical Difficulty in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus: A Retrospective Study with a Large Cohort from China

• by Chaoyan He, Rongjin Zhang, Hua Zhang, Shudong Zhang, Shumin Wang

• February 3, 2026